E.E. Geduld’s iShares Biotechnology ETF IBB Stock Holding History

E.E. Geduld’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,000	Closed	-$261K	–	171
2016 Q1	$261K	Buy	+3,000	New	+$268K	0.36%	48
2015 Q4	–	Sell	-4,500	Closed	-$455K	–	206
2015 Q3	$455K	Buy	+4,500	New	+$540K	0.43%	44

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

E.E. Geduld's IBB Position: Q2 2016 in Review

E.E. Geduld sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 3,000 shares — an estimated $261K sold.

E.E. Geduld first reported a position in IBB in Q3 2015 and held it in 2 quarters. The position peaked at $455K in Q3 2015. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

E.E. Geduld reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
E.E. Geduld sold 3,000 iShares Biotechnology ETF shares in Q2 2016, an estimated $261K.
E.E. Geduld first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 2 quarters.
E.E. Geduld's iShares Biotechnology ETF position peaked at $455K in Q3 2015.
429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on E.E. Geduld's 13F filing for Q2 2016, filed 8 Aug 2016.